AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 195 filers reported holding AXSOME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $489,000 | -69.5% | 6,000 | -73.3% | 0.13% | -69.4% |
| Q3 2020 | $1,603,000 | -78.4% | 22,500 | -75.0% | 0.44% | -79.7% |
| Q2 2020 | $7,405,000 | -59.2% | 90,000 | -70.8% | 2.14% | -75.7% |
| Q1 2020 | $18,149,000 | -71.1% | 308,500 | -49.2% | 8.80% | -43.4% |
| Q4 2019 | $62,791,000 | +493.8% | 607,500 | +16.3% | 15.55% | +103.7% |
| Q3 2019 | $10,575,000 | -6.1% | 522,500 | +19.4% | 7.63% | +90.5% |
| Q2 2019 | $11,266,000 | – | 437,500 | – | 4.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |